glp-1-ras Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_ra_pharmacology [TUSOM | Pharmwiki]
Description
There is increasing concern about the development of pancreatitis in patients with diabetes mellitus who received long-term glucagon-like peptide-1 (GLP-1) analog treatment
![glp-1-ras Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1_cellular_moa.png)
Discover effective weight loss treatments at iThriveMD
![glp-1-ras Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig1_HTML.png)
Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024
No Cold Chain: Because they are chemically stable, they dont require the expensive refrigerated shipping and storage that injectables do
![glp-1-ras Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/359199250/figure/fig1/AS:11431281081130351@1661532031197/Physiologic-effects-of-GLP-1-adapted-from-Granata-et-al-11.png)
Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.
![glp-1-ras Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://www.biochempeg.com/usr/uploads/3/202209/Biological-actions-of%20-GLP-1.png)